Navigation Links
Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
Date:12/8/2011

BURLINGTON, Mass., Dec. 8, 2011 /PRNewswire/ -- Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that an oral presentation on CND0-109 will be given at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition to be held December 10-13, 2011 at the San Diego Convention Center in California.  CNDO-109 is a biologic that activates natural killer (NK) cells for the treatment of acute myeloid leukemia (AML) and solid tumors.

Oral session: Acute Myeloid Leukemia - Therapy, excluding Transplantation: Phase I Trials and Biologic Correlates, Room 30, Tuesday, December 13, 2011, 07:30 – 9:00 AM PT.

"Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML" (Abstract #946), P Kottaridis et. al., Royal Free Hampstead NHS Trust & University College Medical School, London, UK.

For more details on the congress, please visit the official congress web site:

http://www.hematology.org/Meetings/Annual-Meeting/

About CNDO-109

CNDO-109 is a novel anti-cancer drug that primes natural killer (NK) cells without the need for cytokine (IL-2) treatment and shows significant potential for the treatment of hematological and solid tumors. CNDO-109 has produced impressive results in a Phase I clinical trial in patients with AML and demonstrated preclinical activity in multiple myeloma, breast cancer, prostate cancer and ovarian cancer. Coronado plans to file an IND and initiate a Phase I/II dose escalation trial in AML patients in early 2012. 

About Coronado Biosciences

Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents.  The Company's two principal pharmaceutical product candid
'/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
5. Milestone Biosciences, LLC Further Strengthens Executive Management Team
6. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
7. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
10. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
11. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... on the products of cells grown under simulated embryonic ... international license agreement with Suneva Medical, Inc. for physician-dispensed ... (CCM). , This agreement is an amendment ...
(Date:1/14/2014)... BURLINGAME, Calif. , Jan. 14, 2014 As pet owners ... no doubt many of them wrote: "Take better care of my ... and even designer clothes and top-brand carrying cases to take the ... Pet parents might also feel compelled to buy some pricey toys ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... Md., Aug. 18, 2011 The Plasma Protein Therapeutics ... Medicaid Services (CMS) take necessary steps to improve drug ... At last week,s Advisory Panel on Ambulatory ... continued failure by CMS to remove hospitals that purchase ...
... Aug. 18, 2011 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p0588171/Global-Genetic-Testing-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics In a ... represents a highly attractive segment. Genetic testing ...
... 2011 Poplar Healthcare, a leading laboratory services company, ... the existing entities known as GI Pathology, D-PATH Dermatopathology ... expand," remarks William McDowell, CEO of Poplar Healthcare, "we ... brand to which our individual companies could belong, while ...
Cached Biology Technology:PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies 2PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies 3PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies 4Global Genetic Testing Market Analysis 2Global Genetic Testing Market Analysis 3Poplar Healthcare Forms Parent Company, Launches New Web Site 2
(Date:4/17/2014)... University of Texas Medical Branch at Galveston are ... with radiation for cervical cancer should begin colorectal ... The UTMB researchers, finding a high incidence of ... with radiation, offer new recommendations that the younger ... about eight years after their initial cervical cancer ...
(Date:4/17/2014)... Domestication," a special feature of The ... PNAS ) published April 29, raises a number of ... that most of us take for granted. At the ... spots around the globe shifted from hunting animals and ... , It seems so straightforward and yet the more ...
(Date:4/16/2014)... State University researchers have identified a new syndrome called ... and muscle mass with obesity. , "It used to ... better your bones would be because the bones were ... Professor of Nutrition at Florida State. "But, that,s only ...
Breaking Biology News(10 mins):Radiation therapy for cervical cancer increases risk for colorectal cancer 2Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4Researchers: Obesity can amplify bone and muscle loss 2
... to Research Careers) Program has announced the travel award recipients ... Annual Meeting in Portland, Oregon from July 31 August ... entry of underrepresented minority students, postdoctorates and scientists into the ... participation of young scientists at the 2011 SSR Annual Meeting. ...
... The Federation of American Societies for Experimental Biology (FASEB) ... will be the recipient of the FASEB 2012 Excellence ... outstanding career achievements in biological science have contributed significantly ... excellence in research. This prestigious award, sponsored in total ...
... and suspect your body,s working against you, you may be right, ... . "When obese persons reduce their food intake too drastically, ... have to work harder and go slower in order to outsmart ... U of I College of Medicine and a member of U ...
Cached Biology News:FASEB 2012 Excellence in Science Award recipient announced 2Obese dieters' brain chemistry works against their weight-loss efforts 2
... uses a simplified procedure and streamlines the ... kit is based on the three step ... sodium bisulfite where cytosine is converted into ... in-column desulphonation reaction eliminates several precipitation steps ...
... [1320] to RFC1 Immunogen Recombinant protein ... Factor C expressed in E. coli. Reactivity ... cerevisiae. Not yet tested in other species. This ... Background Information Replication factor C is ...
... The enzyme glycerol 3-phosphate dehydrogenase catalyzes ... (DHAP) and glycerol 3-phosphate, with NAD ... significantly during differentiation of progenitor cells ... of this enzyme has been used ...
... is a K-12 strain ideally suited as ... high transformation efficiency, blue/white screening capability (with ... result in high yields of excellent quality ... is potentially useful as a stringent host ...
Biology Products: